Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente ANTIVIRAL RESEARCH

Tipo Año Título Fuente
Artículo2024The absence of seroconversion after exposition to hepatitis C virus is not related to KIR-HLA genotype combinations (GEHEP-012 study)ANTIVIRAL RESEARCH
Artículo2020Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failureANTIVIRAL RESEARCH
Artículo2020Effect of antiviral treatment in older patients hospitalized with confirmed influenzaANTIVIRAL RESEARCH
Artículo2019Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1ANTIVIRAL RESEARCH
Artículo2018Analysis of spontaneous resolution of cytomegalovirus replication after transplantation in CMV-seropositive patients with pretransplant CD8+IFNG + responseANTIVIRAL RESEARCH
Artículo2018Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countriesANTIVIRAL RESEARCH
Artículo2018Inhibition of adenovirus infection by mifepristoneANTIVIRAL RESEARCH
Artículo2016Prevention strategies differentially modulate the impact of cytomegalovirus replication on CD8(+) T-cell differentiation in high-risk solid organ transplant patientsANTIVIRAL RESEARCH
Artículo2015Maraviroc Clinical Test (MCT) as an alternative tool to decide CCR5-antagonists prescription in naive HIV-infected patientsANTIVIRAL RESEARCH
Artículo2015Safety, efficacy and indications of prescription of maraviroc in clinical practice: Factors associated with clinical outcomesANTIVIRAL RESEARCH
Artículo2014Maintenance of virologic efficacy and decrease in levels of beta 2-microglobulin, soluble CD40L and soluble CD14 after switching previously treated HIV-infected patients to an NRTI-sparing dual therapyANTIVIRAL RESEARCH
Artículo2012HIV-coinfection leads to a modest increase in plasma HCV-RNA load in patients with chronic HCV infectionANTIVIRAL RESEARCH
Artículo2012No influence of antiretroviral therapy on the mutation rate of the HCV NS5B polymerase in HIV/HCV-coinfected patientsANTIVIRAL RESEARCH
Artículo2012Patients on a combined antiretroviral therapy after maraviroc clinical test show no immunovirological impairmentANTIVIRAL RESEARCH
Artículo2011Discordance rates between Trofile (R) test and short-term virological response to maravirocANTIVIRAL RESEARCH
Artículo2011Sensitivity of seven HIV subtyping tools differs among subtypes/recombinants in the Spanish cohort of naive HIV-infected patients (CoRIS)ANTIVIRAL RESEARCH
Artículo2010Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa (R)), in antiretroviral-naive patients: A 48-week, multicentre, randomized study (Lake Study)ANTIVIRAL RESEARCH
Artículo2004Genotypic resistance profile in treatment-experienced HIV-infected individuals after abacavir and efavirenz salvage regimenANTIVIRAL RESEARCH